Related Experiment Video

Updated: Aug 21, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells

Lou Yinjun1, Jin Jie, Wang Yungui

  • 1Department of Hematology, Institute of Hematology, The First Affiliated Hospital of ZheJiang University, Hangzhou, ZheJiang 310003, China.

Leukemia Research
|November 16, 2004
PubMed

Insights

Triptolide effectively inhibits multiple myeloma (MM) cell proliferation and induces apoptosis. This natural compound activates key caspases and down-regulates NF-kappaB, showing promise for MM treatment.

Area of Science:

  • Pharmacology
  • Oncology
  • Immunology

Background:

  • Triptolide is recognized for its efficacy in treating autoimmune diseases.
  • Multiple myeloma (MM) is a hematological malignancy with limited treatment options.

Purpose of the Study:

  • To investigate the cytotoxic effects of triptolide on multiple myeloma cells.
  • To elucidate the mechanisms underlying triptolide-induced cell death in MM.

Main Methods:

  • Cell proliferation assays using RPMI8226 and U266 MM cell lines.
  • Apoptosis induction analysis via caspase activation (caspase 8, 9, 3) and PARP cleavage.
  • Cell-cycle analysis and annexin V staining for apoptosis confirmation.
  • Assessment of nuclear factor-kappaB (NF-kappaB) activity.
  • Evaluation of chemosensitivity to doxorubicin and proliferation of fresh MM cells.

Main Results:

  • Triptolide demonstrated dose-dependent inhibition of MM cell proliferation (10-80 ng/mL).
  • Apoptosis was induced through activation of caspase 8, 9, and 3, leading to poly (ADP-ribose) polymerase cleavage.
  • Triptolide suppressed NF-kappaB activity in MM cell lines.
  • Enhanced sensitivity to doxorubicin and reduced proliferation in fresh MM cells were observed.

Conclusions:

  • Triptolide is a potent inducer of apoptosis in multiple myeloma cells.
  • Triptolide exhibits potential therapeutic benefits for patients with multiple myeloma.
  • Further research into triptolide as a myeloma treatment is warranted.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...